Skip to main content
See every side of every news story
Published loading...Updated

TriSalus Life Sciences swaps board members

Arjun Desai has stepped down from the board of directors at TriSalus Life Sciences Inc. (Nasdaq: TLSI), a Westminster-based oncology company, and is being replaced by Michael Stansky. “Mr. Stansky brings 40 years of investment management and healthcare experience, advising and serving on the boards of numerous public and private healthcare companies. Most recently, Mr. Stansky served as a Managing Director at Tudor Investment Corporation, a glob…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BizWest broke the news in on Wednesday, February 11, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal